JF
KYMR icon

Jump Financial’s Kymera Therapeutics KYMR Stock Holding History

Jump Financial’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
+13,803
New +$1.19M 0.01% 986
2025
Q1 		– Sell
-9,666
Closed -$389K – 1829
2024
Q4 		$389K Sell
9,666
-1,425
-13% -$64.4K 0.01% 1199
2024
Q3 		$525K Sell
11,091
-12,426
-53% -$549K 0.01% 1085
2024
Q2 		$702K Buy
+23,517
New +$814K 0.01% 976
2021
Q2 		– Sell
-18,037
Closed -$701K – 1256
2021
Q1 		$701K Buy
+18,037
New +$1.09M 0.07% 316

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Jump Financial's KYMR Position: Q2 2026 in Review

Jump Financial opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 13,803 shares worth $1.58M. The stake represents 0.01% of the portfolio and ranks #986 among its holdings. This is a return to the name: Jump Financial previously reported a position in KYMR as recently as Q4 2024.

Jump Financial first reported a position in KYMR in Q1 2021 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Jump Financial held 13,803 shares of Kymera Therapeutics worth $1.58M as of Q2 2026.
  • Kymera Therapeutics was a new Jump Financial position in Q2 2026.
  • Kymera Therapeutics made up 0.01% of Jump Financial's portfolio in Q2 2026, its #986 holding.
  • Jump Financial first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.